Case number 2018-2097
Valeant Pharmaceuticals Intl. v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | VALEANT PHARMACEUTICALS INTL. v. MYLAN PHARMACEUTICALS INC. [OPINION] [precedential] (0) |
| Jul 31, 2020 | 97 | Mandate issued to the United States District Court for the District of New Jersey. Service as of this date by the Clerk of Court. [711565] [JAB] [Entered: 07/31/2020 10:59 AM] (2) |
| Jul 24, 2020 | 96 | ORDER filed denying [94] petition for panel rehearing, for en banc rehearing filed by Wyeth LLC, Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc. and Progenics Pharmaceuticals, Inc. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [709837] [JAB] [Entered: 07/24/2020 09:31 AM] (2) |
| Jun 24, 2020 | 95 | 18 paper copies of the combined petition for panel rehearing and rehearing en banc [94] received from Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., et al. [703531] [MJL] [Entered: 06/25/2020 08:11 AM] (0) |
| Jun 22, 2020 | 94 | Petition for panel rehearing, for en banc rehearing filed by Appellees Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc. and Wyeth LLC. Service: 06/22/2020 by email. [702876] [18-2097] [Bryan Diner] [Entered: 06/22/2020 04:37 PM] (47) |
| Apr 24, 2020 | 93 | ORDER filed granting motion to extend time to file petition for rehearing/en banc [91] filed by Appellees Wyeth LLC, Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc. and Progenics Pharmaceuticals, Inc. Petition for Rehearing due on or before 06/22/2020. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [689669] [JAB] [Entered: 04/24/2020 08:51 AM] (2) |
| Apr 22, 2020 | 92 | Bill of Costs for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 04/22/2020 by email. [689215] [18-2097] [Robert Florence] [Entered: 04/22/2020 02:37 PM] (0) |
| Apr 22, 2020 | 91 | MOTION of Appellees Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc. and Wyeth LLC to extend the time to file a Petiton for Panel Rehearing until 06/22/2020 [Consent: unopposed]. Service: 04/22/2020 by email. [689190] [18-2097] [Bryan Diner] [Entered: 04/22/2020 01:59 PM] (12) |
| Apr 8, 2020 | 90 | JUDGMENT. REVERSED AND REMANDED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellee(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [685161] [JAB] [Entered: 04/08/2020 10:51 AM] (2) |
| Apr 8, 2020 | 89 | OPINION filed for the court by Lourie, Circuit Judge; Reyna, Circuit Judge and Hughes, Circuit Judge. Precedential Opinion. [685159] [JAB] [Entered: 04/08/2020 10:50 AM] (16) |
| Feb 4, 2020 | 88 | Submitted after ORAL ARGUMENT by Mr. Robert Florence for Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited and Mr. Bryan Diner for Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc. and Wyeth LLC. Panel: Judge: Lourie , Judge: Reyna , Judge: Hughes. [668176] [JCP] [Entered: 02/04/2020 10:24 AM] (0) |
| Jan 15, 2020 | 87 | Response to notice of oral argument from the Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. [663579] [18-2097] [Robert Florence] [Entered: 01/15/2020 09:06 PM] (3) |
| Jan 15, 2020 | 86 | Response to notice of oral argument from the Appellees Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc. and Wyeth LLC. [663345] [18-2097] [Bryan Diner] [Entered: 01/15/2020 01:28 PM] (2) |
| Dec 17, 2019 | 85 | NOTICE OF ORAL ARGUMENT. Panel: 2002D. Case scheduled February 4, 2020 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to Notice of Oral Argument due: 01/15/2020. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [657255] [MJL] [Entered: 12/17/2019 04:35 PM] (2) |
| Nov 14, 2019 | 84 | **TEXT ONLY** ORDER granting motion to withdraw attorney Sharad Bijanki as counsel [83] filed by Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [649146] [TAM] [Entered: 11/14/2019 08:43 AM] (0) |
| Nov 5, 2019 | 83 | MOTION of Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc. to withdraw counsel Sharad Bijanki [Consent: unopposed]. Service: 11/05/2019 by email. [646935] [18-2097] [Robert Florence] [Entered: 11/05/2019 01:09 PM] (6) |
| Oct 28, 2019 | 82 | **TEXT ONLY** ORDER granting motion to withdraw attorney Kristi L. McIntyre as counsel [81] filed by Appellees Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc. and Progenics Pharmaceuticals, Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [645085] [TAM] [Entered: 10/28/2019 11:26 AM] (0) |
| Oct 24, 2019 | 81 | MOTION of Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc. to withdraw counsel Kristi L. McIntyre [Consent: unopposed]. Service: 10/24/2019 by email. [644437] [18-2097] [Bryan Diner] [Entered: 10/24/2019 01:17 PM] (7) |
| Oct 3, 2019 | 80 | Amended Certificate of Interest for Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 10/03/2019 by email. [640164] [18-2097] [Bryan Diner] [Entered: 10/03/2019 05:43 PM] (4) |
| Sep 5, 2019 | 79 | The following conflict dates submitted by Attorney Robert Florence for Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited have been accepted by the court: 11/04/2019, 11/05/2019, 11/06/2019, 11/07/2019, 11/08/2019, 12/02/2019, 12/03/2019, 12/04/2019, 12/05/2019, 12/06/2019. [633347] [JAB] [Entered: 09/05/2019 12:21 PM] (0) |
| Sep 4, 2019 | 78 | The following conflict dates submitted by Attorney Mr. Bryan Diner for Appellees Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc. and Progenics Pharmaceuticals, Inc. have been accepted by the court: 11/04/2019, 11/05/2019, 11/06/2019, 11/07/2019, 11/08/2019. [633029] [MJL] [Entered: 09/04/2019 12:00 PM] (0) |
| Sep 3, 2019 | 77 | MODIFIED ENTRY: Notice from Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc. regarding conflicts with oral argument. Service: 09/03/2019 by email. [632803]--[Edited 09/04/2019 by MJL to correct event] [Robert Florence] [Entered: 09/03/2019 03:30 PM] (4) |
| Sep 3, 2019 | 76 | Notice from Appellees Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc. and Wyeth LLC regarding conflicts with oral argument. Service: 09/03/2019 by email. [632726] [18-2097] [Bryan Diner] [Entered: 09/03/2019 01:41 PM] (4) |
| Aug 30, 2019 | 75 | 6 paper copies of the Appendix Brief [66] received from Appellants Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and Wyeth LLC. [632658] [CJF] [Entered: 09/03/2019 11:29 AM] (0) |
| Aug 30, 2019 | 74 | 6 paper copies of the Reply Brief [65] received from Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. [632656] [CJF] [Entered: 09/03/2019 11:27 AM] (0) |
| Aug 30, 2019 | 73 | 6 paper copies of the Corrected Opening Brief [56] received from Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. [632654] [CJF] [Entered: 09/03/2019 11:27 AM] (0) |
| Aug 28, 2019 | 72 | 6 paper copies of the Opening Response Brief [64] received from Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and Wyeth LLC. [631717] [CJF] [Entered: 08/28/2019 02:32 PM] (0) |
| Aug 27, 2019 | 71 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [631373] [TAM] [Entered: 08/27/2019 02:32 PM] (1) |
| Aug 27, 2019 | 70 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(1). [631371] [TAM] [Entered: 08/27/2019 02:30 PM] (0) |
| Aug 13, 2019 | 69 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc., Progenics Pharmaceuticals, Inc. and Wyeth LLC. Service: 08/13/2019 by email. [627857] [18-2097] [Bryan Diner] [Entered: 08/13/2019 11:03 AM] (3) |
| Aug 13, 2019 | 68 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 08/13/2019 by email. [627829] [18-2097] [Robert Florence] [Entered: 08/13/2019 10:07 AM] (3) |
| Aug 13, 2019 | 67 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and Wyeth LLC. Service: 08/13/2019 by email. [627828] [18-2097] [Robert Florence] [Entered: 08/13/2019 10:03 AM] (5) |
| Aug 13, 2019 | 66 | MODIFIED ENTRY: APPENDIX FILED for Mylan Inc., Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. and Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and Wyeth LLC. Number of Pages: 635. Service: 08/13/2019 by email. [627826] --[Edited 08/27/2019 by TAM - compliance review complete] [Robert Florence] [Entered: 08/13/2019 10:01 AM] (635) |
| Aug 6, 2019 | 65 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Number of Pages: 26. Service: 08/06/2019 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [626531] --[Edited 08/22/2019 by TAM - compliance review complete] [Robert Florence] [Entered: 08/06/2019 08:31 PM] (35) |
| Jul 2, 2019 | 64 | MODIFIED ENTRY: BRIEF FILED for Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and Wyeth LLC. Number of Pages: 57. Service: 07/02/2019 by email. [618765] --[compliance review complete - Edited 07/16/2019 by SMJ] [Bryan Diner] [Entered: 07/02/2019 09:34 PM] (71) |
| Jun 25, 2019 | 63 | Entry of appearance for Jonathon Brugh Lower as of counsel for Appellee Wyeth LLC. Service: 06/25/2019 by email. [616908] [18-2097] [Jonathon Lower] [Entered: 06/25/2019 04:50 PM] (2) |
| Jun 7, 2019 | 62 | Amended Certificate of Interest for the Appellees Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc. and Progenics Pharmaceuticals, Inc.. Service: 06/07/2019 by email. [612540] [18-2097] [Bryan Diner] [Entered: 06/07/2019 04:07 PM] (4) |
| May 14, 2019 | 61 | ORDER granting motion to extend time to file Appellees' response brief [60] filed by Appellees Wyeth LLC, Valeant Pharmaceuticals International, Inc., Salix Pharmaceuticals, Inc. and Progenics Pharmaceuticals, Inc. Appellees' response brief is due 07/02/2019. Appellants' reply brief is due 08/06/2019. Service as of this date by the Clerk of Court. [607054] [TAM] [Entered: 05/14/2019 08:55 AM] (2) |
| May 10, 2019 | 60 | MOTION of Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and Wyeth LLC to extend the time to 07/02/2019 to file the Plaintiffs-Appellees' Response Brief. [Consent: unopposed]. Service: 05/10/2019 by email. [606558] [18-2097] [Bryan Diner] [Entered: 05/10/2019 02:13 PM] (12) |
| Apr 23, 2019 | 59 | ORDER filed. The motion [57] is granted. Appellees' response brief is due no later than June 18, 2019. No further extensions should be anticipated. Service: 04/23/2019 by clerk. [602312] [LMS] [Entered: 04/23/2019 03:27 PM] (2) |
| Apr 22, 2019 | 58 | RESPONSE of Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc. to the motion to extend time to file brief [57] filed by Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and Wyeth LLC. Service: 04/22/2019 by email. [601812] [18-2097] [Robert Florence] [Entered: 04/22/2019 10:43 AM] (42) |
| Apr 17, 2019 | 57 | MOTION of Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc. and Wyeth LLC to extend the time to 06/18/2019 to file the Response brief of Plaintiffs-Appellees. [Consent: opposed]. Service: 04/17/2019 by email. [600951] [18-2097] [Bryan Diner] [Entered: 04/17/2019 11:20 AM] (16) |
| Apr 16, 2019 | 56 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Number of Pages: 55. Service: 04/16/2019 by email. [600714] --[Edited 04/17/2019 by TAM - compliance review complete] [Robert Florence] [Entered: 04/16/2019 02:49 PM] (119) |
| Apr 16, 2019 | 55 | Notice of Correction to the Brief Doc No. [52] for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 04/16/2019 by email. [600709] [18-2097] [Robert Florence] [Entered: 04/16/2019 02:45 PM] (6) |
| Apr 15, 2019 | 54 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc., Opening Brief [52], is not in compliance with the rules of this court (see attached). Compliant document due on 04/22/2019. Service as of this date by the Clerk of Court.[599973] [TAM] [Entered: 04/15/2019 10:55 AM] (2) |
| Apr 10, 2019 | 53 | Entry of appearance for Cora R. Holt as of counsel for Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 04/10/2019 by email. [599135] [18-2097] [Bryan Diner] [Entered: 04/10/2019 07:22 PM] (2) |
| Apr 9, 2019 | 52 | FILED from Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Title: OPENING BRIEF. Service: 04/09/2019 by email. [598831] [18-2097] This document is non-compliant. See Doc No. [54] [Robert Florence] [Entered: 04/09/2019 07:24 PM] (119) |
| Apr 3, 2019 | 51 | Amended Certificate of Interest for the Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 04/03/2019 by email. [597620] [18-2097] [Bryan Diner] [Entered: 04/03/2019 03:15 PM] (4) |
| Feb 20, 2019 | 49 | Entry of appearance for Micheal L. Binns as of counsel for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 02/20/2019 by email. [587442] [18-2097] [Micheal Binns] [Entered: 02/20/2019 12:47 PM] (2) |
| Feb 20, 2019 | 50 | Entry of appearance for Sharad K. Bijanki as of counsel for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 02/20/2019 by email. [587444] [18-2097] [Sharad Bijanki] [Entered: 02/20/2019 12:53 PM] (2) |
| Feb 20, 2019 | 48 | Entry of appearance for Karen L. Carroll as of counsel for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 02/20/2019 by email. [587438] [18-2097] [Karen Carroll] [Entered: 02/20/2019 12:39 PM] (2) |
| Feb 20, 2019 | 47 | ORDER filed unsealing the precedential court order [42]. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [587320] [17-2312, 17-2636, 18-2097] [JAB] [Entered: 02/20/2019 09:22 AM] (3) |
| Feb 19, 2019 | 46 | RESPONSE of Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc. to the court order to set briefing schedule [43] , court order to show cause [43] , court order to lift stay [43] , court order to reschedule argument [43] , court order [43]. Service: 02/15/2019 by email. [586754] [18-2097] [Bryan Diner] [Entered: 02/17/2019 04:39 PM] (3) |
| Feb 11, 2019 | 45 | SEALED ERRATA to the court order Doc No.: [42]. Service as of this date by the Clerk of Court. [584666] [17-2312, 17-2636, 18-2097] [JAB] [Entered: 02/11/2019 09:36 AM] (0) |
| Feb 8, 2019 | 44 | Entry of appearance for Robert L. Florence as principal counsel for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Service: 02/08/2019 by email. [584520] [18-2097] [Robert Florence] [Entered: 02/08/2019 02:18 PM] (2) |
| Feb 8, 2019 | 43 | ORDER filed. Joint response to the show cause order is due on or before 02/15/2019. The court’s stay on the briefing on the merits is hereby lifted. Appellants’ initial brief is due within 60 days of this order. By: Per Curiam. Service as of this date by the Clerk of Court. [584413] [JAB] [Entered: 02/08/2019 11:02 AM] (0) |
| Feb 8, 2019 | 42 | SEALED PRECEDENTIAL ORDER filed granting motion to disqualify [527170-2] in 17-2312, granting motion to disqualify [527163-2] filed by Appellant Salix Pharmaceuticals, Inc. in 17-2636, granting motion to disqualify [34] filed by Appellees Valeant Pharmaceuticals International, Inc. and Salix Pharmaceuticals, Inc. in 18-2097. By: Lourie, Circuit Judge; O'Malley, Circuit Judge; and Reyna, Circuit Judge. Service as of this date by the Clerk of Court. [584346] [17-2312, 17-2636, 18-2097]--[Edited 02/20/2019 by JAB to unseal document pursuant to court's order] [JAB] [Entered: 02/08/2019 09:29 AM] (20) |
| Sep 12, 2018 | 41 | Submitted after ORAL ARGUMENT by Michael Isidoro Verde for Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited and Charles E. Lipsey for Valeant Pharmaceuticals International, Inc., and Salix Pharmaceuticals, Inc. Panel: Judge: Lourie , Judge: O'Malley , Judge: Reyna. [549101] [JAB] [Entered: 09/12/2018 10:45 AM] (0) |
| Sep 7, 2018 | 40 | Entry of appearance for Jonathan Rotenberg as of counsel for Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited. Service: 09/07/2018 by email. [547930] [18-2097] [Jonathan Rotenberg] [Entered: 09/07/2018 11:44 AM] (2) |
| Aug 17, 2018 | 39 | Entry of appearance for Michael I. Verde as of counsel for Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited. Service: 08/17/2018 by email. [543799] [18-2097] [Michael Verde] [Entered: 08/17/2018 03:28 PM] (2) |
| Aug 17, 2018 | 38 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:calendar response Docket No. [37], ERROR: Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc. submitted a response to the oral argument order designating Michael I. Verde as arguing attorney. CORRECTION: The attorney is not in compliance with FCR 47.3. An Entry of Appearance must be filed on behalf of the arguing attorney. [543596] [JAB] [Entered: 08/17/2018 08:58 AM] (0) |
| Aug 15, 2018 | 37 | Response to oral argument order from the Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals Inc.. Designating Michael I. Verde to argue.. Designating 30 minutes for argument. Reserving 0 minutes for rebuttal. [18-2097] [Michael Verde] [Entered: 08/15/2018 01:08 PM] (0) |
| Aug 14, 2018 | 36 | Response to oral argument order from the Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Designating Charles E. Lipsey, Esq. to argue.. Designating 15 minutes for argument. Reserving 10 minutes for rebuttal. [18-2097] [Bryan Diner] [Entered: 08/14/2018 01:33 PM] (0) |
| Jul 31, 2018 | 35 | Sealed or confidential document received [MOTION of Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc. to disqualify Katten Muchin Rosenman LLP as Counsel for Appellants (Corrected Confidential Version).] (corresponding to Doc No. [34]) for Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/31/2018 by email. [539908] [18-2097] [Bryan Diner] [Entered: 07/31/2018 09:27 PM] (0) |
| Jul 31, 2018 | 34 | MOTION of Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc. to disqualify Katten Muchin Rosenman LLP as Counsel for Appellants (Corrected Non-Confidential Version). [Consent: opposed]. Service: 07/31/2018 by email. [539907] [18-2097] [Bryan Diner] [Entered: 07/31/2018 09:14 PM] (408) |
| Jul 31, 2018 | 33 | Notice of Correction to the motion to disqualify Doc No. [19] for Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/31/2018 by email. [539905] [18-2097] [Bryan Diner] [Entered: 07/31/2018 08:14 PM] (3) |
| Jul 31, 2018 | 32 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: certificate of interest Docket No. [29], ERROR: Listed names of parties represented and real parties in interest do not match party names used in the official caption. CORRECTION: In the future, counsel must either use party names as listed in official caption or move to have the caption revised. [539614] [JAB] [Entered: 07/31/2018 09:55 AM] (0) |
| Jul 26, 2018 | 31 | REPLY of Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc. to response filed by Appellants, Doc. No [25]. Service: 07/26/2018 by email. [538895] [18-2097] [Bryan Diner] [Entered: 07/26/2018 07:31 PM] (195) |
| Jul 26, 2018 | 30 | Entry of appearance for Jessica M. Lebeis as of counsel for Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/26/2018 by email. [538894] [18-2097] [Bryan Diner] [Entered: 07/26/2018 07:23 PM] (2) |
| Jul 26, 2018 | 29 | Amended Certificate of Interest for the Appellees Valeant Pharmaceuticals International, Inc., Progenics Pharmaceuticals, Inc. and Salix Pharmaceuticals, Inc.. Service: 07/26/2018 by email. [538893] [18-2097] [Bryan Diner] [Entered: 07/26/2018 07:19 PM] (4) |
| Jul 26, 2018 | 28 | NOTICE OF CALENDARING. Panel: 1809J. Cases scheduled Sep 12, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 201. Response to oral argument order due: 08/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [538760] THIS NOTICE APPLIES TO CASE(S): [17-2312, 17-2636, 18-2097] [JAB] [Entered: 07/26/2018 01:37 PM] (0) |
| Jul 26, 2018 | 27 | ORDER filed scheduling oral argument on the pending motions to disqualify and intervene for Wednesday, September 12, 2018 at 10:00 a.m. in Courtroom 201. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [538758] [17-2312, 17-2636, 18-2097] [JAB] [Entered: 07/26/2018 01:32 PM] (3) |
| Jul 24, 2018 | 26 | Notice from Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc. regarding conflicts with oral argument (Parties jointly submit this notice to advise the Court that all parties are available for oral argument on the following dates: no availability in Aug.; parties are available Sept.6,7,12-14; and available Oct. 22, 29-31, 2018). Service: 07/24/2018 by email. [538242] [18-2097] [Bryan Diner] [Entered: 07/24/2018 03:52 PM] (6) |
| Jul 19, 2018 | 25 | RESPONSE of Appellants Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited to the motion [19] filed by Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/19/2018 by email. [537126] [18-2097] [Deepro Mukerjee] [Entered: 07/19/2018 05:00 PM] (105) |
| Jul 17, 2018 | 24 | ORDER filed staying briefing on the merits in appeal 18-2097; response to [20] confidential document, [19] motion to disqualify due 07/19/2018 in appeal 18-2097; counsel must notify the court of argument conflicts for the entire months of August, September, and October. [see order for details]. By: (Per Curiam). Service as of this date by the Clerk of Court. [536450] [17-2312, 17-2636, 18-2097] [SJ] [Entered: 07/17/2018 11:36 AM] (5) |
| Jul 13, 2018 | 23 | Official caption revised to remove comma in Appellant Mylan Pharmaceuticals Inc.'s name. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [535605] [JAB] [Entered: 07/13/2018 08:43 AM] (0) |
| Jul 9, 2018 | 22 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The contact information on the entry of appearance for Stephanie M. Roberts [21] does not match the information in the attorney's user account. CORRECTION: ECF account information may be updated at www.pacer.gov, or counsel may file an amended EOA. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [534465] [CMP] [Entered: 07/09/2018 02:17 PM] (0) |
| Jul 9, 2018 | 21 | Entry of appearance for Stephanie M. Roberts as of counsel for Appellants Mylan Pharmaceuticals, Inc., Mylan Laboratories Limited and Mylan Inc.. Service: 07/09/2018 by email. [534271] [18-2097] [Stephanie Roberts] [Entered: 07/09/2018 09:49 AM] (2) |
| Jul 9, 2018 | 20 | Sealed or confidential document received [Confidential Motion of Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc. to disqualify Katten Muchin Rosenman LLP as Counsel for Appellants.] (corresponding to Doc No. [19]) for Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/07/2018 by email. [534203] [18-2097] [Bryan Diner] [Entered: 07/07/2018 12:35 AM] (0) |
| Jul 9, 2018 | 19 | MOTION of Appellees Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc. to disqualify Katten Muchin Rosenman LLP as Counsel for Appellants. [Consent: opposed]. Service: 07/07/2018 by email. [534202] [18-2097] [Bryan Diner] [Entered: 07/07/2018 12:26 AM] (404) |
| Jul 6, 2018 | 18 | Docketing Statement for the Appellee Wyeth LLC. Service: 07/06/2018 by email. [534188] [18-2097] [Bryan Diner] [Entered: 07/06/2018 06:51 PM] (4) |
| Jul 6, 2018 | 17 | Certificate of Interest for the Appellee Wyeth LLC. Service: 07/06/2018 by email. [534182] [18-2097] [Bryan Diner] [Entered: 07/06/2018 06:26 PM] (3) |
| Jul 6, 2018 | 16 | Entry of appearance for Charles H. Chevalier as principal counsel for Appellee Wyeth LLC. Service: 07/06/2018 by email. [534180] [18-2097] [Bryan Diner] [Entered: 07/06/2018 06:24 PM] (2) |
| Jul 6, 2018 | 15 | Docketing Statement for the Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/06/2018 by email. [534177] [18-2097] [Bryan Diner] [Entered: 07/06/2018 06:15 PM] (4) |
| Jul 6, 2018 | 14 | Certificate of Interest for the Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/06/2018 by email. [534175] [18-2097] [Bryan Diner] [Entered: 07/06/2018 06:13 PM] (4) |
| Jul 6, 2018 | 13 | Entry of appearance for Kristi L. McIntyre as of counsel for Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/06/2018 by email. [534174] [18-2097] [Bryan Diner] [Entered: 07/06/2018 06:11 PM] (2) |
| Jul 6, 2018 | 12 | Entry of appearance for Esther H. Lim as of counsel for Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/06/2018 by email. [534173] [18-2097] [Bryan Diner] [Entered: 07/06/2018 06:09 PM] (2) |
| Jul 6, 2018 | 11 | Entry of appearance for Charles E. Lipsey as of counsel for Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/06/2018 by email. [534171] [18-2097] [Bryan Diner] [Entered: 07/06/2018 06:07 PM] (2) |
| Jul 6, 2018 | 10 | Entry of appearance for Justin J. Hasford as of counsel for Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/06/2018 by email. [534170] [18-2097] [Bryan Diner] [Entered: 07/06/2018 06:04 PM] (2) |
| Jul 6, 2018 | 9 | Entry of appearance for Bryan C. Diner as principal counsel for Appellees Progenics Pharmaceuticals, Inc., Salix Pharmaceuticals, Inc. and Valeant Pharmaceuticals International, Inc.. Service: 07/06/2018 by email. [534169] [18-2097] [Bryan Diner] [Entered: 07/06/2018 06:02 PM] (2) |
| Jul 6, 2018 | 8 | Certificate of Interest for the Appellants Mylan Pharmaceuticals, Inc., Mylan Laboratories Limited and Mylan Inc.. Service: 07/06/2018 by email. [534134] [18-2097] [Deepro Mukerjee] [Entered: 07/06/2018 04:12 PM] (3) |
| Jul 6, 2018 | 7 | Docketing Statement for the Appellants Mylan Pharmaceuticals, Inc., Mylan Inc. and Mylan Laboratories Limited. Service: 07/06/2018 by email. [534131] [18-2097] [Deepro Mukerjee] [Entered: 07/06/2018 04:08 PM] (3) |
| Jul 6, 2018 | 6 | Entry of appearance for Lance A. Soderstrom as of counsel for Appellants Mylan Pharmaceuticals, Inc., Mylan Laboratories Limited and Mylan Inc.. Service: 07/06/2018 by email. [534120] [18-2097] [Lance Soderstrom] [Entered: 07/06/2018 03:51 PM] (2) |
| Jul 6, 2018 | 5 | Entry of appearance for Deepro R. Mukerjee as principal counsel for Appellants Mylan Pharmaceuticals, Inc., Mylan Laboratories Limited and Mylan Inc.. Service: 07/06/2018 by email. [534116] [18-2097] [Deepro Mukerjee] [Entered: 07/06/2018 03:45 PM] (2) |
| Jul 6, 2018 | 4 | Entry of appearance for Eric T. Werlinger as of counsel for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals, Inc.. Service: 07/06/2018 by email. [534113] [18-2097] [Eric Werlinger] [Entered: 07/06/2018 03:40 PM] (2) |
| Jul 6, 2018 | 3 | Entry of appearance for Howard R. Rubin as of counsel for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals, Inc.. Service: 07/06/2018 by email. [534111] [18-2097] [Howard Rubin] [Entered: 07/06/2018 03:33 PM] (2) |
| Jul 6, 2018 | 2 | Entry of appearance for Rajesh R. Srinivasan as of counsel for Appellants Mylan Inc., Mylan Laboratories Limited and Mylan Pharmaceuticals, Inc.. Service: 07/06/2018 by email. [534107] [18-2097] [Rajesh Srinivasan] [Entered: 07/06/2018 03:27 PM] (2) |
| Jun 22, 2018 | 1 | Appeal docketed. Received: 06/20/2018. [531395]Entry of Appearance due 07/06/2018. Certificate of Interest is due on 07/06/2018. Docketing Statement due 07/06/2018. Appellant/Petitioner's brief is due 08/21/2018. [SJ] [Entered: 06/22/2018 09:31 AM] (67) |
